Method of treating actinic keratosis
Described is a novel approach for treating actinic keratosis which involves the use of urea in a dermatological composition. The urea composition can be included in pre-treatment, treatment and post-treatment steps. Also described are novel topical compositions for the treatment step containing a combination of urea and a pharmaceutical agent for treating actinic keratosis, such as a caustic agent, 5-fluorouracil or a photosensitizing agent.
1 . A method for treating actinic keratosis on an area of skin of a patient comprising:
(a) pre-treating the area by applying a composition comprising from about 10 to about 60 wt-% of urea, and the balance being dermatologically acceptable excipients;
(b) administering a treatment for actinic keratosis concurrently with the composition comprising from about 10 to about 60 wt-% urea.
2 . The method of claim 1 , wherein the urea composition contains an antioxidant.
3 . The method of claim 2 , wherein the antioxidant is vitamin E.
4 . The method of claim 1 , wherein further post-treating the area by applying a composition comprising from about 10 to about 60 wt-% of urea and the balance being dermatologically acceptable excipients.
5 . The method of claim 4 , wherein the urea composition comprises an antioxidant.
6 . The method of claim 5 , wherein the antioxidant is vitamin E.
7 . The method of claim 1 , wherein the treatment for actinic keratosis is selected from the group consisting of cryosurgery, removal or excision with a scalpel, dermabrasion, laser surgery, electrosurgical skin resurfacing, irradiation, administration of a therapeutically effective amount of a pharmaceutical agent, and a combination thereof.
8 . The method of claim 7 , wherein the pharmaceutical agent is selected from the group consisting of a caustic agent, a photosensitizing agent, 5-fluorouracil, masoprocol, retinoids, α-hydroxy acids, interferon, and a combination thereof.
9 . The method of claim 7 , wherein the treatment comprises administering a photosensitizing pharmaceutical agent and subsequent irradiation of the area.
10 . The method of claim 9 , wherein the photosensitizing agent is 5-aminolevulinic acid or a salt thereof.
11 . The method of claim 9 , wherein the photosensitizing agent is methoxsalen or a derivative thereof.
12 . The method of claim 8 , wherein the pharmaceutical agent is 5-fluorouracil.
13 . The method of claim 7 , wherein the pharmaceutical agent is included in a composition comprising from about 10 to about 60 wt-% of urea and the balance being dermatologically acceptable excipients.
14 . The method of claim 13 , wherein the pharmaceutical agent is included in a composition comprising from about 21 to about 40 wt-% of urea and the balance being dermatologically acceptable excipients.
15 . The method of claim 14 , wherein the pharmaceutical agent is included in a composition comprising about 40 wt-% of urea and the balance being dermatologically acceptable excipients.
16 . The method of claim 1 , wherein the pre-treatment urea composition and the concurrent urea composition comprise from about 21 wt-% to about 40 wt-% urea.
17 . The method of claim 1 , wherein the pre-treatment urea composition and the concurrent urea composition comprise about 40 wt-% urea.